VAN DE SANDE, M. .; TAP, W. D.; GELHORN, H. L.; YE, X.; SPECK, R. M. .; PALMERINI, E.; STACCHIOTTI, S.; DESAI, J.; WAGNER, A. J.; ALCINDOR, T.; GANJOO, K.; MARTÍN-BROTO, J. .; WANG, Q. .; SHUSTER, D.; GELDERBLOM, H.; HEALEY, J. H. Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial. Acta Orthopaedica, [S. l.], v. 92, n. 4, p. 493–499, 2021. DOI: 10.1080/17453674.2021.1922161. Disponível em: https://scandjms.sfulib10.publicknowledgeproject.org/index.php/actao/article/view/1190. Acesso em: 24 aug. 2026.